Magnetic Resonance Imaging of the Lung: Oncological Applications
Fondazione IRCCS Policlinico San Matteo di Pavia
50 participants
Jan 15, 2020
OBSERVATIONAL
Conditions
Summary
Lung neoplasms are characterized by a complex interaction between tumor cells and a variety of resident and infiltrating host elements, secreted factors, and extracellular matrix proteins, collectively referred to as the microenvironment. Nowadays, in the setting of lung cancer, and in particular non-small cell lung cancer (NSCLC), the evaluation of microenvironment characteristics can only be performed by a pathologist and only on histological material. By combining different MRI parameters, it may be possible to create a specific imaging "signature" for the three different immune phenotypes and thus be able to make a distinction based on MRI examination.
Eligibility
Inclusion Criteria3
- Primary NSCLC of the lung (TNM 8th edition T parameter ≥T1c)
- Biopsy examination of the primary tumor adequate at least for PDL-1 quantification
- Staging CT scan with uncertain N parameter and definite M parameter.
Exclusion Criteria1
- Absolute contraindications to magnetic resonance imaging or the administration of gadolinium-based contrast agents
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07486219